Document:

Employment Agreement between NeoGenomics, Inc. and Robert J. Shovlin

 EXHIBIT 10.1 

EMPLOYMENT AGREEMENT 

THIS EMPLOYMENT AGREEMENT (“Agreement”) is made this 18th day of September, 2014 by and between NeoGenomics, Inc. a Nevada
corporation (“NeoGenomics” or the “Employer” and collectively with any entity that is wholly or partially owned by NeoGenomics, the “Company”), located at 12701 Commonwealth Drive, Suite #5, Fort
Myers, Florida 33913 and Robert J. Shovlin (“Executive”), an individual who resides at 15 Pine Tree Road, Ramsey, NJ 07446. 

RECITALS: 
 WHEREAS,
the Company is engaged in the business of providing genetic and molecular diagnostic testing services to doctors, hospitals and other healthcare institutions; and 

WHEREAS, NeoGenomics desires to employ Executive as an officer in the capacity of Chief Operating Officer, and Executive desires to be
employed by NeoGenomics in such capacity, in accordance with the terms, covenants, and conditions as set forth in this Agreement. 
 NOW,
THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Employer and Executive agree as follows: 

1. Employment and Term. Subject to the terms and conditions set forth in this Agreement, the Company hereby offers and the Employee hereby
accepts employment beginning on October 13, 2014, or such other date as may be mutually agreed upon in writing (the “Effective Date”). The Employee’s employment with the Company will be “at will” as such term is
construed under Florida law. Either the Employee or the Company may terminate such employment at any time and for any reason, subject to the provisions of Section 5 hereof. For purposes of this Agreement, the period from the Effective Date
until the termination of the Executive’s employment shall hereinafter be referred to as the “Term”. 
 2. Position and
Duties. 
 a) Position. During the Term hereof, Executive shall serve the Company as the Chief Operating Officer
(“COO”) of both NeoGenomics, Inc., the parent company, and NeoGenomics Laboratories, Inc., the primary operating subsidiary, or such other position or positions as the Company may in the future determine, at such location or
locations as the Company may determine after consultation with the Executive. Executive will report to and be subject to the general supervision and direction of the Chief Executive Officer (“CEO”) of the Company. If requested,
Executive will serve in similar capacities for each or any subsidiary of NeoGenomics without additional compensation. 
 b)
Duties. Executive shall perform such duties as are customarily performed by someone holding the title of COO in the same or similar businesses or enterprises as that engaged in by the Company and such other duties as the CEO may assign
from time to time. Executive shall devote his full business time and his best efforts, business judgment, skill and knowledge exclusively to the advancement of the business and interests of the Company and its affiliates and to the discharge of his
duties and responsibilities hereunder. Executive shall not engage in any other business activity or serve in any industry, trade, professional, governmental or academic position during the Term, except as may be expressly in advance by the Board of
Directors of the Company (the “Board”) in writing; provided, however, that Executive may, without advance approval, participate in charitable activities and passive personal activities, provided that such activities do not,
individually or in the aggregate, interfere with the performance of Executive’s duties under this Agreement, are not in conflict with the business interests of the Company or any of its affiliate, and do not violate the terms of that certain
Confidentiality, Non-Solicitation and Non-Compete Agreement attached hereto as Addendum A. 

  
 1 

 c) Compliance with Policies, Practices, etc. During the Term hereof, Executive
shall comply with all Company policies, practices and procedures and all codes of ethics and or business conduct as may be in effect for officers of the Company from time to time. 

3. Compensation and Benefits of Executive. The Company shall compensate Executive for Executive’s services rendered under this Agreement as
follows: 
  

	 	a)	Base Salary. Unless otherwise adjusted by the Compensation Committee of the Board (the “Compensation Committee”), the Company shall pay Executive a base salary of $325,000 per annum (the
“Base Salary”), payable in equal installments at such times as is consistent with normal Company payroll policy. 

  

	 	b)	Bonus. Executive will be eligible for a performance-based bonus as a participant in the Company’s Management Incentive Plan (“MIP”), which shall set annual target incentives for the
Executive and other senior ranking employees that are determined by the Compensation Committee. The Company will target an annual bonus of up to 40% of the Executive’s Base Salary (the “Target Bonus”), with the actual amount of
the bonus, if any, to be determined by and in the sole discretion of the Compensation Committee after consideration of specified metrics established by the Board or the Compensation Committee for such fiscal year. Executive shall be eligible to
receive up to 150% of the Target Bonus in the event that the Company’s and/or the Executive’s performance exceeds the thresholds set for the Target Bonus. Except as otherwise agreed to by the parties in writing, Executive must be employed
hereunder on the last day of a fiscal year in order to be eligible for a bonus for such fiscal year. 

  

	 	c)	Benefits. Subject to the eligibility requirements (including, but not limited to, participation by part-time employees), and enrollment provisions of the Company’s employee benefit plans, Executive
may, to the extent he so chooses, participate in any and all of the Company’s employee benefit plans, at the Company’s expense. All Company benefits are identified in the Employee Handbook and are subject to change without notice or
explanation. In addition, subject to the eligibility requirements (including, but not limited to, participation by a part-time employee) and enrollment provisions of the Company’s executive benefit programs, Executive shall also be entitled to
participate in any and all other benefits programs established for officers of the Company. 

  

	 	d)	Stock Options. On the Effective Date, Executive will be granted an option to purchase 300,000 shares of the Company’s common stock (the “Options”) on the terms and conditions listed
below. Such Options will have a strike price equal to the fair market value of the common stock as of the Effective Date, which pursuant to NeoGenomics’ Amended and Restated Equity Incentive Plan (the “Plan”), shall be equal to
the closing price per share of NeoGenomics’ common stock on the last trading day immediately preceding the Effective Date. The vesting provisions of such Options shall be as outlined below. These Options shall be treated as incentive stock
options (ISOs) to the maximum extent permitted under applicable law, and the remainder of the Options, if any, shall be treated as non-qualified stock options. The grant of these Options will be made pursuant to the Company’s Plan and will be
evidenced by a separate “Option Agreement” to be executed by the Company and Executive, which will contain all the terms and conditions of the Options (including, but not limited to, the provisions set forth in this
Section 3(d)). So long as Executive remains employed by the Company, such Options will have a five (5) year term before expiration. 

  
 2 

					
	 Vesting
	 	  	 
	 	75,000	  	  	will vest on the first anniversary of the Effective Date
		
	 	6,250	  	  	will vest each month beginning on the 13th monthly anniversary of the Effective Date and continuing on each monthly anniversary thereafter until the fourth anniversary of the
Effective Date

  

	 	  	Executive understands that, pursuant to the Plan, upon termination of his employment, he will only have ninety (90) days to exercise any vested portion of the Options. All Options awarded pursuant to this
Section 3(d) will contain a provision in the Option Agreement that allows for immediate vesting of any unvested portion of the Options in the event of that a change of control of NeoGenomics is consummated on or after the first anniversary of
the Effective Date. In the event of that a change of control of NeoGenomics is consummated prior to the first anniversary of the Effective Date, half of any remaining unvested Options shall be deemed vested. 

 

	 	e)	Paid Time-Off and Holidays. Executive’s paid time-off (“PTO”) and holidays shall be consistent with the standards set forth in the Company’s Employee Handbook, as revised from
time to time or as otherwise published by the Company. Notwithstanding the previous sentence, Executive will be eligible for one hundred sixty (160) hours of PTO/year, which will accrue on a pro-rata basis throughout the year, provided,
however, that it is the Company’s policy that no more than forty (40) hours of PTO can be accrued beyond this annual limit for any employee at any time. Thus, when accrued PTO reaches two hundred (200) hours, Executive will cease
accruing PTO until accrued PTO is one hundred sixty (160) hours or less, at which point Executive will again accrue PTO until he reaches two hundred (200) hours. In addition to PTO, there are also six (6) paid national holidays and
one (1) “floater” day available to Company employees. Executive agrees to schedule such PTO so that it minimally interferes with the Company’s operations. Such PTO does not include Board excused absences. 

 

	 	f)	Reimbursement of Normal Business Expenses. The Company will reimburse all reasonable business expenses of Executive, including, but not limited to, cell phone expenses and business related travel, meals
and entertainment expenses in accordance with the Company’s polices for such reimbursement. 

 4. Termination. The parties
agree that any termination of the Executive under this Agreement will be governed as follows: 
  

	 	a)	By the Company for Cause. The Company shall have the right to terminate this Agreement and to discharge the Executive for Cause (as defined below), at any time during the Term. For the purposes of this
Agreement, the Company shall have “Cause” to terminate the Executive’s employment hereunder upon: 

 (i)
failure to materially perform and discharge the duties and responsibilities of Executive under this Agreement after receiving written notice and allowing Executive ten (10) business days to create a plan to cure such failure(s), such plan being
acceptable to the Board of Directors, and a further thirty (30) days to cure such failure(s), if so curable, provided, however, that after one such notice has been given to Executive and the thirty (30) day cure period has lapsed,
the Company is no longer required to provide time to cure subsequent failures under this provision, or 

  
 3 

 (ii) any breach by Executive of the material provisions of this Agreement; or 

(iii) misconduct which, in the good faith opinion and sole discretion of the Board of Directors, is injurious to the Company; or 

(iv) felony conviction involving the personal dishonesty or moral turpitude of Executive; or a determination by the Board, after consideration
of all available information, that Executive has willfully and knowingly violated Company policies or procedures involving discrimination, harassment, or work place violence; or 

(v) engagement in illegal drug use or alcohol abuse which prevents Executive from performing his duties in any manner, or 

(vi) any misappropriation, embezzlement or conversion of the Company’s opportunities or property by the Executive; or 

(vii) willful misconduct, recklessness or gross negligence by the Executive in respect of the duties or obligations of the Executive under this
Agreement and/or the Confidentiality, Non-Solicitation or Non-Competition Agreement. 
  

	 	  	Any termination for Cause pursuant to this Section shall be given to the Executive in writing and shall set forth in detail all acts or omissions upon which the Company is relying to terminate the Executive for Cause.
If an Executive is terminated for Cause, the Executive shall only be entitled to receive his accrued and unpaid Salary, bonus and other benefits through the termination date and the Company shall have no further obligations under this Agreement from
and after the date of termination. 

  

	 	b)	Termination by Company Without Cause. At any time during the Term, the Company shall have the right to terminate this Agreement and to discharge the Executive without Cause effective upon delivery of
written notice to the Executive. If the Company terminates the Executive without “Cause” for any reason, then the Company agrees that as severance it will continue to pay the Executive’s Base Salary in accordance with
Section 3(a) (the “Severance Payments”) for twelve (12) months from the date of the notice of termination. Executive further agrees that in the event that he obtains employment during any period where Severance Payments
are being made, he will promptly notify the Company of the nature of his new employment. Provided that such employment does not violate the terms of the Confidentiality, Non-Solicitation and Non-Compete Agreement, such Severance Payments will
continue to be paid. Other than the Severance Payments, the Company shall have no further obligation to the Executive after the date of such termination; provided, however, that the Executive shall only be entitled to continuation of the
Severance Payments as long as he is in compliance with the provisions of the Confidentiality, Non-Solicitation & Non-Compete Agreement, which is part of this Agreement. If termination without cause shall occur at any time, then the pro rata
portion of any unvested time-based options (as specified in Section 3(d)) up until the date of notice of termination that are due to vest in the year or month of termination shall vest. 

 

	 	  	The Executive acknowledges and agrees that any and all payments to which he would be entitled under this Paragraph 5b are conditioned upon and subject to his execution of a general waiver and release, in such reasonable
form as counsel for the Company shall determine, of all claims the Executive has or may have against the Company. 

  
 4 

	 	c)	By Resignation of the Executive. The Executive may terminate his employment hereunder, upon giving sixty (60) days written notice to the Company. The Executive agrees that, unless otherwise agreed
upon in writing, during such sixty (60) day period no more than one week of unused PTO may be utilized and that all other unused PTO up to the time of termination shall be forfeited. In the event of such a termination, the Executive shall
comply with any reasonable request of the Company to assist in providing for an orderly transition of authority, but such assistance shall not delay the Executive’s termination of employment longer than the Executive’s original notice of
termination. Upon such a termination, the Executive shall become entitled to any accrued but unpaid salary and other benefits up to and including the date of termination and the pro rata portion of any unvested time-based options (as specified in
Section 3(d)) up until the date of separation that are due to vest in the year or month of separation shall vest. 

  

	 	d)	Disability of the Executive. This Agreement may be terminated by the Company upon the Disability of the Executive. “Disability” shall mean any mental or physical illness, condition, disability or
incapacity which prevents the Executive from reasonably discharging his duties and responsibilities under this Agreement for a period of ninety (90) days in any one hundred eighty (180) day period. In the event that any disagreement or
dispute shall arise between the Company and the Executive as to whether the Executive suffers from any Disability, then, in such event, the Executive shall submit to the physical or mental examination of a physician licensed under the laws of the
State of Florida, who is agreeable to the Company and the Executive, and such physician shall determine whether the Executive suffers from any Disability. In the absence of fraud or bad faith, the determination of such physician shall be final and
binding upon the Company and the Executive. The entire cost of such examination shall be paid solely by the Company. In the event the Company has purchased disability insurance for Executive, the Executive shall be deemed disabled if he is disabled
as defined by the terms of the disability policy. On the date that the Executive is deemed to have a Disability, this Agreement will be deemed to have been terminated and the Executive shall be entitled to receive from the Company his accrued and
unpaid Base Salary, bonus and other benefits through the termination date. If a termination of the Executive by Disability shall occur at any time, then the pro rata portion of any unvested time-based options (as specified in Section 3(d)) up
until the date of the Executive’s termination that were due to vest in the year or month of the Executive’s termination shall vest. Other than as set forth in the immediately preceding two sentences, the Company shall have no further
salary or bonus payment or other benefits obligations under this Agreement from and after the date of termination due to Disability. 

  

	 	e)	Death of the Executive. In the event of the death of Executive, the employment of the Executive by the Company shall automatically terminate on the date of the Executive’s death and the Company shall
be obligated to pay Executive’s estate (i) the Executive’s accrued and unpaid Base Salary, bonus and other benefits through the termination date. If the death of the Executive shall occur at any time, than the pro rata portion of any
unvested time-based options up until the date of the Executive’s death that were due to vest in the year or month of the Executive’s death shall vest. Other than as set forth in the immediately preceding two sentences, the Company shall
have no further obligations under this Agreement from and after the date of termination due to the death of the Executive. 

  
 5 

 5. Effect of Termination. The provisions of this Section 5 shall apply to any termination of
the Executive’s employment under this Agreement, whether pursuant to Section 4 or otherwise. 
  

	 	a)	Provision by the Company of Severance Payments, if any, due to the Executive in accordance with this Agreement shall constitute the entire obligation of the Company to the Executive hereunder. The Executive shall
promptly give the Company notice of all facts necessary for the Company to determine the amount and duration of its obligations in connection with any termination pursuant to this Agreement. 

 

	 	b)	Except for any right of the Executive to continue medical, vision, or dental plan participation in accordance with applicable law or as expressly provided herein, the Executive’s participation in all Employee
Benefit Plans shall terminate pursuant to the terms of the applicable plan documents based on the date of termination of the Executive’s employment without regard to any Severance Payments, notice required hereunder, or any other payment made
to or on behalf of the Executive following such date of termination. 

  

	 	c)	Provisions of this Agreement shall survive any termination of the Executive’s employment if so provided herein or if necessary or desirable fully to accomplish the purposes of other surviving provisions, including
without limitation the obligations of the Executive under the Confidentiality, Non-Solicitation & Non-Compete Agreement. The obligation of the Company to provide Severance Payments hereunder is expressly conditioned on the Executive’s
continued full compliance with the terms of the Confidentiality, Non-Compete & Non-Solicitation Agreement. The Executive acknowledges that, except as expressly provided in Section 4(b), no compensation is earned after termination of
employment. 

 6. Confidentiality, Non-Solicitation & Non-Compete Agreement. Executive agrees to the terms of the
Confidentiality, Non-Solicitation and Non-Compete Agreement attached hereto as Addendum A and has signed that Agreement. Such Confidentiality, Non-Solicitation and Non-Compete Agreement is hereby incorporated into and made a part of this
Agreement. 
 7. Importance of Certain Clauses. Executive and Employer agree that the covenants contained in the Confidentiality,
Non-Solicitation and Non-Compete Agreement attached hereto and incorporated into this Agreement are material terms of this Agreement and all parties understand the importance of such provisions to the ongoing business of the Employer. As such,
because the Employer’s continued business and viability depend on the protection of such secrets and non-competition, these clauses are interpreted by the parties to have the widest and most expansive applicability as may be allowed by law and
Executive understands and acknowledges his or her understanding of same. 
 8. Consideration. Executive acknowledges and agrees that the
provision of employment under this Agreement and the execution by the Employer of this Agreement constitute full, adequate and sufficient consideration to Executive for the Executive’s duties, obligations and covenants under this Agreement and
under the Confidentiality, Non-Solicitation and Non-Compete Agreement incorporated into this Agreement. 
 9. Acknowledgement of Post Termination
Obligations. Upon the effective date of termination of Executive’s employment (unless due to Executive’s death), if requested by the Employer, Executive shall participate in an exit interview with the Employer and certify in
writing that Executive has complied with his contractual obligations and intends to comply with his continuing obligations under this Agreement, including, but not limited to, the terms of the Confidentiality, Non-Solicitation and Non-Compete
Agreement. To the extent it is known or applicable at the time of such exit interview, Executive shall also provide the Employer with information concerning Executive’s subsequent employer and the capacity in which Executive will be employed.
Executive’s failure to comply shall be a material breach of this Agreement, for which the Employer, in addition to any other civil remedy, may seek equitable relief. 

  
 6 

 10. Withholding. All payments made to Executive shall be made net of any applicable withholding for
income taxes and Executive’s share of FICA, FUTA or other employment taxes. The Company shall withhold such amounts from such payments to the extent required by applicable law and remit such amounts to the applicable governmental authorities in
accordance with applicable law. 
 11. Representations of Executive. Executive represents and warrants to NeoGenomics that (a) nothing in
his past legal and/or work and/or personal experiences, which if became broadly known in the marketplace, would impair his ability to serve as the Chief Operating Officer of a publicly-traded company or materially damage his credibility with public
shareholders; (b) he has not been convicted of any criminal offense related to health care, or been debarred, sanctioned, excluded or otherwise made ineligible for participation in a federal or state health care program by any federal or state
agency; (c) there are no restrictions, agreements, or understandings whatsoever to which he is a party which would prevent or make unlawful his execution of this Agreement or employment hereunder, (d) Executive’s execution of this
Agreement and his employment hereunder shall not constitute a breach of any contract, agreement or understanding, oral or written, to which he is a party or by which he is bound, (e) Executive is free and able to execute this Agreement and to
continue employment with NeoGenomics, and (f) Executive has not used and will not use confidential information or trade secrets belonging to any prior employers to perform services for the Company. 

12. Compliance Agreements. Executive agrees to provide services to the Company in compliance with all applicable federal and state laws and
regulations, as well as all compliance guidance published by federal or state agencies, including, without limitation, the Medicare and Medicaid anti-kickback law, the Stark self-referral prohibition, and compliance guidance published by the Office
of the Inspector General of the Department of Health and Human Service, and to assist the Company in remaining educated and in compliance with respect to such laws and regulations and compliance guidance. Executive acknowledges that he understands
these requirements, and shall remain educated and informed regarding the applicable federal and state laws and regulations, as well as all compliance guidance published by federal or state agencies. In the event that Executive knows or suspect that
any activities of the Company or any personnel or contractor of the Company, or any client of the Company implicates any such requirements or guidance, he agrees that he will immediately inform the Chief Executive Officer of the Company and
cooperate fully with the Company to investigate and address any compliance issues arising as a result of such known or suspected activities. Executive further understands and acknowledges that compliance with this paragraph shall be a condition of
employment. 
 13. Effect of Partial Invalidity. The invalidity of any portion of this Agreement shall not affect the validity of any other
provision. In the event that any provision of this Agreement is held to be invalid, the parties agree that the remaining provisions shall remain in full force and effect. 

14. Entire Agreement. This Agreement, together with the other documents referenced herein, reflects the complete agreement between the parties
regarding the subject matter identified herein and shall supersede all other previous agreements, either oral or written, between the parties. The parties stipulate that neither of them, nor any person acting on their behalf has made any
representations except as are specifically set forth in this Agreement and each of the parties acknowledges that it or he has not relied upon any representation of any third party in executing this Agreement, but rather have relied exclusively on it
or his own judgment in entering into this Agreement. 
 15. Assignment. Employer may assign its interest and rights under this Agreement at its
sole discretion and without approval of Executive to a successor in interest by the Employer’s merger, consolidation or 

  
 7 

 
other form of business combination with or into a third party where the Employer’s stockholders before such event do not control a majority of the resulting business entity after such event.
All rights and entitlements arising from this Agreement, including but not limited to those protective covenants and prohibitions set forth in the Confidentiality, Non-Solicitation and Non-Compete Agreement attached as Addendum A and incorporated
into this Agreement shall inure to the benefit of any purchaser, assignor or transferee of this Agreement and shall continue to be enforceable to the extent allowable under applicable law. Neither this Agreement, nor the employment status conferred
with its execution is assignable or subject to transfer in any manner by Executive. 
 16. Notices. All notices, requests, demands, and other
communications shall be in writing and shall be given by registered or certified mail, postage prepaid, a) if to the Employer, at the Employer’s then current headquarters location, and b) if to Executive, at the most recent address on file with
the Company for Executive or to such subsequent addresses as either party shall so designate in writing to the other party. 
 17. Remedies. If
any action at law, equity or in arbitration, including an action for declaratory relief, is brought to enforce or interpret the provisions of this Agreement, the prevailing party may, if the court or arbitrator hearing the dispute, so determines,
have its reasonable attorneys’ fees and costs of enforcement recouped from the non-prevailing party. 
 18. Amendment/Waiver. No waiver,
modification, amendment or change of any term of this Agreement shall be effective unless it is in a written agreement signed by both parties. No waiver by the Employer of any breach or threatened breach of this Agreement shall be construed as a
waiver of any subsequent breach unless it so provides by its terms. 
 19. Governing Law, Venue and Jurisdiction. This Agreement and all
transactions contemplated by this Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of Florida without regard to any conflicts of laws, statutes, rules, regulations or ordinances. Executive consents to
personal jurisdiction and venue in the Circuit Court in and for Lee County, Florida regarding any action arising under the terms of this Agreement and any and all other disputes between Executive and Employer. 

20. Arbitration. Any and all controversies and disputes between Executive and Employer arising from this Agreement or regarding any other matter
whatsoever shall be submitted to arbitration before a single unbiased arbitrator skilled in arbitrating such disputes under the American Arbitration Association, utilizing its Commercial Rules. Any arbitration action brought pursuant to this section
shall be heard in Fort Myers, Lee County, Florida. The Circuit Court in and for Lee County, Florida shall have concurrent jurisdiction with any arbitration panel for the purpose of entering temporary and permanent injunctive relief, but only with
respect to any alleged breach of the Confidentiality, Non-Solicitation and Non-Compete Agreement. 
 21. Headings. The titles to the sections
of this Agreement are solely for the convenience of the parties and shall not affect in any way the meaning or interpretation of this Agreement. 
 22.
Miscellaneous Terms. The parties to this Agreement declare and represent that: 
  

	 	a.	They have read and understand this Agreement; 

  

	 	b.	They have been given the opportunity to consult with an attorney if they so desire; 

  

	 	c.	They intend to be legally bound by the promises set forth in this Agreement and enter into it freely, without duress or coercion; 

  

	 	d.	They have retained signed copies of this Agreement for their records; and 

  
 8 

	 	e.	The rights, responsibilities and duties of the parties hereto, and the covenants and agreements contained herein, shall continue to bind the parties and shall continue in full force and effect until each and every
obligation of the parties under this Agreement has been performed. 

 23. Counterparts. This Agreement may be executed in
counterparts and by facsimile, or by pdf, each of which shall be deemed an original for all intents and purposes. 
 Signatures appear on
the following page. 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first written above.

  

			
	NEOGENOMICS, INC., a Nevada Corporation
		
	By:	 	/s/ Douglas VanOort

 
			
		
	Name:	 	Douglas VanOort

 
			
		
	Title:	 	Chairman and CEO

  

	
	EXECUTIVE:
	
	/S/ Robert J. Shovlin
	Robert J. Shovlin

  
 10 

 Addendum A 

Form of Confidentiality, Non-Solicitation & Non-Compete Agreement 

  
 11Confidentiality, Non-solicitation and Non-compete Agreement

 EXHIBIT 10.2 

CONFIDENTIALITY, NON-SOLICITATION AND NON-COMPETE AGREEMENT 

This Confidentiality, Non-Solicitation and Non-Compete Agreement (the “Agreement”) dated this 18th day of September,
2014 is entered into by and between Robert J. Shovlin (“Employee”) and NeoGenomics, Inc., a Nevada corporation (“Employer” or the (“Parent Company”) and collectively with
NeoGenomics Laboratories, Inc., a Florida corporation and any entity that is wholly or partially owned by the Parent Company or otherwise affiliated with the Parent Company, the “Company”). Hereinafter, each of the Employee
or the Company maybe referred to as a “Party” and together be referred to as the “Parties”. 

RECITALS: 

WHEREAS, the Parties have entered into that certain Employment Agreement, of even dated herewith, that creates an employment
relationship between the Employer and Employee (the “Employment Agreement”); and 
 WHEREAS, pursuant to the
Employment Agreement, the Employee agreed to enter into the Company’s Confidentiality, Non-Solicitation and Non-Compete Agreement; and 

WHEREAS, the Company desires to protect and preserve its Confidential Information and its legitimate business interests by having the
Employee enter into this Agreement as part of the Employment Agreement; and 
 WHEREAS, the Employee desires to establish and
maintain an employment relationship with the Company and as part of such employment relationship desires to enter into this Agreement with the Company; and 

WHEREAS, the Employee acknowledges that the terms of the Employment Agreement including, but not limited to the Company’s
commitments to the Employee with respect to base salary, fringe benefits and stock options are sufficient consideration to the Employee for the entry into this Agreement. 

WHEREAS, the Employee acknowledges that substantial cost and expense has been or will be incurred by the Company for Employee’s
training, and Employee’s training and employment have caused, or will require, the disclosure of certain Company confidential and proprietary information, trade secrets and customer and supplier relationships. 

NOW, THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties agree as follows: 
 1. Term. Employee agrees that all of the provisions of this
Agreement except for Sections 7 and 8 hereof shall be effective as of the date of this Agreement. The Company and the Employee agree that Sections 7 and 8 hereof will not become effective until the Employee’s first day of employment with the
Company. Employee agrees that the term of this Agreement (“Term”) shall be as follows: (i) in the event that Employee does not actually become an employee of the Company as contemplated by the Employment Agreement, then
the Term shall be for a period of two (2) years from the date of this Agreement, or (ii) in the event Employee does become an employee of the Company, then the term of this Agreement shall survive and continue to be in force and effect for
two years following the termination of any employment 

  
 1 

 
relationship between the Parties, whether termination is by the Company with or without cause, wrongful discharge, or for any other reason whatsoever, or by the Employee unless an exception is
specifically provided in certain situations in any such Restrictive Covenants. 
 2. Definitions. 

a. The term “Confidential Information” as used herein shall include all business practices, methods, techniques, or
processes that: (i) derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use; and
(ii) is the subject of efforts that are reasonable under the circumstances to maintain its secrecy. Confidential Information also includes, but is not limited to, files, letters, memoranda, reports, records, computer disks or other computer
storage medium, data, models or any photographic or other tangible materials containing such information, Customer lists and names and other information, Customer contracts, other corporate contracts, computer programs, proprietary technical
information and/or strategies, sales, promotional or marketing plans or strategies, programs, techniques, practices, any expansion plans (including existing and entry into new geographic and/or product markets), pricing information, product or
service offering specifications or plans thereof, business plans, financial information and other financial plans, data pertaining to the Company’s operating performance, employee lists, salary information, Personal Information, Protected
Health Information, all information the Company receives from customers or other third parties that is not generally known to the public or is subject to a confidentiality agreement, training manuals, and other materials and business information of
a similar nature, including information about the Company itself or any affiliated entity, which Employee acknowledges and agrees has been compiled by the Company’s expenditure of a great amount of time, money and effort, and that contains
detailed information that could not be created independently from public sources. Further, all data, spreadsheets, reports, records, know-how, verbal communication, proprietary and technical information and/or other confidential materials of similar
kind transmitted by the Company to Employee or developed by the Employee on behalf of the Company as Work Product (as defined in Paragraph 7) are expressly included within the definition of “Confidential Information.” The Parties further
agree that the fact the Company may be seeking to complete a business transaction is “Confidential Information” within the meaning of this Agreement, as well as all notes, analysis, work product or other material derived from Confidential
Information. Nevertheless, Confidential Information shall not include any information of any kind which (1) is in the possession of the Employee prior to the date of this Agreement, as shown by the Employee’s files and records, or
(2) prior or after the time of disclosure becomes part of the public knowledge or literature, not as a result of any violation of this Agreement, any violation of any similar agreement with any other party or inaction or action of the receiving
party, or (3) is rightfully received from a third party without any obligation of confidentiality; or (4) independently developed after termination without reference to the Confidential Information or materials based thereon; or
(5) is disclosed pursuant to the order or requirement of a court, administrative agency, or other government body; or (6) is approved for release by the non-disclosing party. 

b. The term “Personal Information” (“PI”) is Confidential Information and includes, but is not limited
to, an individual’s first name and last name or first initial and last name in combination with any of the following: an individual’s social security number, tax I.D. number, social insurance number, driver’s license number, state
issued identification card number, financial information, healthcare information, or credit or debit card number. 
 c. The term
“Protected Health Information” (“PHI”) is Confidential Information and includes information that is created, received, and/or maintained by the Company related to an individual’s health care (or payment
related to health care) that directly or indirectly identifies the individual. 

  
 2 

 d. The term “Customer” shall mean any person or entity which has
purchased or ordered goods, products or services from the Company and/or entered into any contract for products or services with the Company within the one (1) year immediately preceding the termination of the Employee’s employment with
the Company. 
 e. The term “Prospective Customer” shall mean any person or entity which has evidenced an intention
to order products or services with the Company within one year immediately preceding the termination of the Employee’s employment with the Company. 

f. The term “Restricted Area” shall include any geographical location anywhere in the United States. If the Restricted
Area specified in this Agreement should be judged unreasonable in any proceeding, then the Restricted Area shall be reduced so that the restrictions may be enforced as is judged to be reasonable. 

g. The phrase “directly or indirectly” shall include the Employee either on his/her own account, or as a partner,
owner, promoter, joint venturer, employee, agent, consultant, advisor, manager, executive, independent contractor, officer, director, or a stockholder of 5% or more of the voting shares of an entity in the Business of Company. 

h. The term “Business” shall mean the business of providing non-academic, for-profit cancer genetic and molecular
laboratory testing services, including, but not limited to, cytogenetics, flow cytometry, fluorescence in-situ hybridization (“FISH”), morphological studies, and molecular testing, to hematologists, oncologists, urologists, pathologists,
hospitals and other medical reference laboratories. 
 3. Duty of Confidentiality. 

a. All Confidential Information is considered highly sensitive and strictly confidential. The Employee agrees that at all times during the term
of this Agreement and after the termination of employment with the Company for as long as such information remains non-public information, the Employee shall (i) hold in confidence and refrain from
disclosing to any other party all Confidential Information, whether written or oral, tangible or intangible, concerning the Company and its business and operations unless such disclosure is accompanied by a non-disclosure agreement executed by the
Company with the party to whom such Confidential Information is provided, (ii) use the Confidential Information solely in connection with his or her employment with the Company and for no other purpose, (iii) take all reasonable
precautions necessary to ensure that the Confidential Information shall not be, or be permitted to be, shown, copied or disclosed to third parties, without the prior written consent of the Company, (iv) observe all security policies implemented
by the Company from time to time with respect to the Confidential Information, and (v) not use or disclose, directly or indirectly, as an individual or as a partner, joint venturer, employee, agent, salesman, contractor, officer, director or
otherwise, for the benefit of himself or herself or any other person, partnership, firm, corporation, association or other legal entity, any Confidential Information, unless expressly permitted by this Agreement. Employee agrees that protection of
the Company’s Confidential Information constitutes a legitimate business interest justifying the restrictive covenants contained herein. Employee further agrees that the restrictive covenants contained herein are reasonably necessary to protect
the Company’s legitimate business interest in preserving its Confidential Information. In addition, Employee will not view or access any PI or PHI unless required by the Company in the course Employee’s job duties and responsibilities for
the Company and then only when authorized by the Company to do so. Employee acknowledges that he/she shall bear all costs, losses and damages resulting from any intentional breach of this paragraph, to the fullest extent permitted by applicable law.

  
 3 

 b. In the event that the Employee is ordered to disclose any Confidential Information, whether in
a legal or regulatory proceeding or otherwise, such disclosure shall be limited to the narrowest disclosure so required and, except to the extent prohibited by law, Employee shall give the Company at least two (2) weeks’ notice, if
practicable, of the basis for any such compelled disclosure of Confidential Information and shall reasonably cooperate with the Company in limiting disclosure and obtaining suitable confidentiality protections. 

c. Employee acknowledge(s) that this “Confidential Information” is of value to the Company by providing it with a competitive
advantage over their competitors, is not generally known to competitors of the Company, and is not intended by the Company for general dissemination. Employee acknowledges that this “Confidential Information” derives independent economic
value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use, and is the subject of reasonable efforts to maintain its
secrecy. Therefore, the Parties agree that all “Confidential Information” under this Agreement constitutes “Trade Secrets” under Section 688.002 and Chapter 812 of the Florida Statutes. 

4. Limited Right of Disclosure. Except as otherwise permitted by this Agreement, Employee shall limit disclosure of pertinent Confidential
Information to Employee’s attorney, if any (“Representative(s)”), for the sole purpose of evaluating Employee’s relationship with the Company. Paragraph 3 of this Agreement shall bind all such Representative(s).

 5. Return of Company Property and Confidential Materials. All tangible property, including cell phones, laptop computers and other Company
purchased property, as well as all Confidential Information, Customer and Prospective Customer information and property, provided to Employee is the exclusive property of the Company and must be returned to the Company in accordance with the
instructions of the Company either upon termination of the Employee’s employment or at such other time as is requested by the Company. Employee agree(s) that upon termination of employment for any reason whatsoever Employee shall return all
copies, in whatever form or media, including hard copies and electronic copies, of Confidential Information to the Company, and Employee shall delete any copy of the Confidential Information on any computer file or database maintained by Employee
and shall certify in writing that he/she has done so. In addition to returning all Confidential Information to the Company as described above, Employee will destroy any analysis, notes, work product or other materials relating to or derived from the
Confidential Information. Any retention of Confidential Information may constitute “civil theft” as such term is defined in Chapter 772 of the Florida Statutes. 

6. Agreement Not To Circumvent. Employee agrees not to pursue any transaction or business relationship that is directly competitive to the
Business of the Company that makes use of any Confidential Information during the Term of this Agreement, other than through the Company or on behalf of the Company. It is further understood and agreed that, after the Employee’s employment with
the Company has been terminated, the Employee will direct all communications and requests from any third parties regarding Confidential Information or Business opportunities which use Confidential Information through the Company’s then chief
executive officer or president. Employee acknowledges that any violation of this covenant may subject Employee to the remedies identified in Paragraph 9 in addition to any other available remedies. 

7. Title to Work Product. Employee agrees that all work products (including strategies and testing methodologies for competing in the genetics
testing industry, technical materials and diagrams, computer programs, financial plans and other written materials, websites, presentation materials, course materials, advertising campaigns, slogans, videos, pictures and other materials) created or
developed by the Employee for the Company during the term of the Employee’s employment with the Company or any successor to the Company until the date of termination of the Employee (collectively, the “Work Product”),
shall be considered a work made for hire and that the Company shall be the sole owner of all rights, including copyright, in and to the Work Product.  

  
 4 

 If the Work Product, or any part thereof, does not qualify as a work made for hire, the Employee
agrees to assign, and hereby assigns, to the Company for the full term of the copyright and all extensions thereof all of its right, title and interest in and to the Work Product. All discoveries, inventions, innovations, works of authorship,
computer programs, improvements and ideas, whether or not patentable or copyrightable or otherwise protectable, conceived, completed, reduced to practice or otherwise produced by the Employee in the course of his or her services to the Company in
connection with or in any way relating to the Business of the Company or capable of being used or adapted for use therein or in connection therewith shall forthwith be disclosed to the Company and shall belong to and be the absolute property of the
Company unless assigned by the Company to another entity. 
 Employee hereby assigns to the Company all right, title and interest in all of
the discoveries, inventions, innovations, works of authorship, computer programs, improvements, ideas and other work product; all copyrights, trade secrets, and trademarks in the same; and all patent applications filed and patents granted worldwide
on any of the same for any work previously completed on behalf of the Company or work performed under the terms of this Agreement or the Employment Agreement. Employee, if and whenever required to do so (whether during or after the termination of
his or her employment), shall at the expense of the Company apply or join in applying for copyrights, patents or trademarks or other equivalent protection in the United States or in other parts of the world for any such discovery, invention,
innovation, work of authorship, computer program, improvement, and idea as aforesaid and execute, deliver and perform all instruments and things necessary for vesting such patents, trademarks, copyrights or equivalent protections when obtained and
all right, title and interest to and in the same in the Company absolutely and as sole beneficial owner, unless assigned by the Company to another entity. Notwithstanding the foregoing, work product conceived by the Employee, which is not related to
the Business of the Company, will remain the property of the Employee. 
 8. Restrictive Covenant. The Company and its affiliated entities are
engaged in the Business of providing genetic and molecular testing services. The covenants contained in this Paragraph 8 (the “Restrictive Covenants”) are given and made by Employee to induce the Company to employ Employee
under the terms of the Employment Agreement, and Employee acknowledges sufficiency of consideration for these Restrictive Covenants. Employee expressly covenants and agrees that, during his or her employment and for a period of two (2) years
following termination of such employment (such period of time is hereinafter referred to as the “Restrictive Period”), he/she will abide by the following restrictive covenants unless an exception is specifically provided, in
writing signed by Company, in certain situations in such Restrictive Covenants. Notwithstanding the forgoing, the Company agrees that the Restrictive Period of the Non-Competition Covenant described in paragraph 8(b) below shall be reduced to one
year in the event that the Company consummates a change of control within the first year of the Employee’s employment with the Company and the Employee is terminated without “Cause” (as such term is defined in the Employment
Agreement) within ninety (90) days of the effective date of such change of control. 
  

	 	a.	Non-Solicitation. Employee agrees and acknowledges that, during the Restrictive Period, he/she will not, directly or indirectly, in one or a series of transactions, as an individual or as a partner, joint
venturer, employee, agent, salesperson, contractor, officer, director or otherwise, for the benefit of himself or herself or any other person, partnership, firm, corporation, association or other legal entity: 

  
 5 

	 	(i)	solicit or induce, or attempt to solicit or induce, any Customer or Prospective Customer of the Company to patronize or do business with any other company (or business) that is in the Business conducted by the Company
in the Restricted Area; or 

  

	 	(ii)	request or advise any Customer, supplier or vendor, or any Prospective Customer, prospective supplier or prospective vendor, of the Company, who was a Customer, Prospective Customer, supplier, prospective supplier,
vendor or prospective vendor within one year immediately preceding the termination of the Employee’s employment with the Company, to withdraw, curtail, cancel or refrain from doing business with the Company in any capacity; or

  

	 	(iii)	manage, operate, be connected with, employed by, sell goods to, or perform services for, or on behalf of, in any manner, any Customer, or Prospective Customer, of the Company either myself or on behalf of any other
entity that may employ, engage or associate with me in any fashion. 

  

	 	(iv)	recruit, solicit or otherwise induce any proprietor, partner, stockholder, lender, director, officer, employee, sales agent, joint venturer, investor, lessor, supplier, Customer, agent, representative or any other
person which has a business relationship with the Company or any Affiliated Entity to discontinue, reduce or detrimentally modify such employment, agency or business relationship with the Company; or 

 

	 	(v)	employ or solicit, or attempt to employ or solicit, for employment any person or agent who is then (or was at any time within twelve (12) months prior to the date Employee or any entity related to Employee seeks to
employ such person) employed or retained by the Company. Notwithstanding the forgoing, to the extent the Employee works for a larger firm or corporation after his or her termination from the Company and he or she does not have any personal knowledge
and/or control over the solicitation of or the employment of a Company employee or agent, then this provision shall not be enforceable as it relates to that employee. 

 

	 	b.	Non-Competition. Employee agrees and acknowledges that, during the Restrictive Period, he or she will not, directly or indirectly, for himself , or on behalf of others, as an individual on Employee’s
own account, or as a partner, joint venturer, employee, agent, salesman, contractor, officer, director or otherwise, for him/herself or any other person, partnership, firm, corporation, association or other legal entity, enter into, engage in,
accept employment from, or provide any services to, or for, any business that is in the Business of the Company, or engage in any activity that is competitive with the Company, in the Restricted Area. The parties agree that
this non-competition provision is intended to cover situations where a future business opportunity in which the Employee is engaged or a future employer of the Employee is selling the same or similar products and services in a Business which may
compete with the Company’s products and services to Customers and Prospective Customers of the Company in the Restricted Area. This provision shall not cover future business opportunities or employers of the Employee that sell different types
of products or services in the Restricted Area so long as such future business opportunities or employers are not in the Business of the Company. 

  

	 	  	 Notwithstanding the preceding paragraphs, the spirit and intent of this non-competition clause is not to deny the Employee the ability to support his
or her family, but rather to prevent the Employee from using the knowledge and experiences obtained from the Company in a similar competitive environment. Along those lines, should the Employee leave the employment of the Employer for any reason, he
or she would be prohibited from joining a for-profit cancer testing 

  
 6 

	 	
genetics laboratory and/or company in the Business of the Company in the Restricted Area. The Parties agree that all non-profit medical testing laboratories, hospitals and academic institutions
as well as for-profit prenatal and pediatric/constitutional genetic testing laboratories are excluded from the restrictions in paragraph 8(b). In other words, the Employee would be allowed under this non-compete clause to work in any non-profit
cancer genetics testing laboratory (e.g., in academia) as well as in a private, for-profit prenatal laboratory or pediatric/constitutional genetics testing laboratory. Thus, the spirit and intent of this non-competition clause is intended to prevent
the Employee from acting in any of the capacities outlined in this paragraph for any “for-profit” cancer genetics testing laboratories that do the type of any one or more of the types of testing defined in the definition of Business in the
Restricted Area. 

 9. Acknowledgements of Employee. 
  

	 	a.	The Employee understands and acknowledges that any violation of this Agreement shall constitute a material breach of this Agreement and the Employment Agreement, and it will cause irreparable harm and loss to the
Company for which monetary damages will be an insufficient remedy. Therefore, the Parties agree that in addition to any other remedies available, the Company will be entitled to the relief identified in Paragraph No. 10 below.

  

	 	b.	The Restrictive Covenants shall be construed as agreements independent of any other provision in this Agreement and the existence of any claim or cause of action of Employee against the Company shall not constitute a
defense to the enforcement of these Restrictive Covenants. 

  

	 	c.	Employee agrees that the Restrictive Covenants are reasonably necessary to protect the legitimate business interests of the Company. 

 

	 	d.	Employee agrees that this Agreement may be enforced by the Company’s successor in interest by way of merger, business combination or consolidation where a majority of the surviving entity is not owned by
Company’s shareholders who owned a majority of the Company’s voting shares prior to such transaction and Employee acknowledges and agrees that successors are intended beneficiaries of this Agreement. 

 

	 	e.	Employee agrees that if any portion of the Restrictive Covenants is held by a court of competent jurisdiction to be unreasonable, arbitrary or against public policy for any reason, such shall be modified accordingly as
to time, geographic area and line of business so as to be enforceable to the fullest extent possible as to time, area and line of business. 

  

	 	f.	Employee acknowledges that any violations of the Agreement will be a material breach of this Agreement and may subject the Employee, and/or any individual(s), partnership, corporation, joint venture or other type of
business with whom the Employee is then affiliated or employed, to monetary and other damages. 

  

	 	g.	Employee agrees that any failure of the Company to enforce the Restrictive Covenants against any other employee, for any reason, shall not constitute a defense to enforcement of the Restrictive Covenants against the
Employee. 

 10. Specific Performance; Injunction. The Parties agree and acknowledge that the restrictions contained in
Paragraphs 1-8 are reasonable in scope and duration and are necessary to protect the Company. If any provision of Paragraphs 1-8 as applied to any party or to any circumstance is judged by a court to be invalid or unenforceable, the same shall in no
way affect any other circumstance or the 

  
 7 

 
validity or enforceability of any other provision of this Agreement. If any such provision, or any part thereof, is held to be unenforceable because of the duration of such provision or the area
covered thereby, the court making such determination shall have the power to reduce the duration and/or area of such provision, and/or to delete specific words or phrases, and in its reduced form, such provision shall then be enforceable and shall
be enforced. 
 Any unauthorized use or disclosure of Confidential Information in violation of Paragraphs 2-7 above or violation of the
Restrictive Covenant in Paragraph 8 shall constitute a material breach of this Agreement and will cause irreparable harm and loss to the Company for which monetary damages may be an insufficient remedy. Therefore, in addition to any other remedy
available, the Company will be entitled to all available civil remedies, including: 
  

	 	a.	Temporary and permanent injunctive relief, without the necessity of posting a bond, restraining Employee or Representatives and any other person, partnership, firm, corporation, association or other legal entity acting
in concert with Employee from any actual or threatened unauthorized disclosure or use of Confidential Information, in whole or in part, or from rendering any service to any other person, partnership, firm, corporation, association or other legal
entity to whom such Confidential Information in whole or in part, has been disclosed or used or is threatened to be disclosed or used; and 

  

	 	b.	Temporary and permanent injunctive relief, without the necessity of posting a bond, restraining the Employee from violating, directly or indirectly, the restrictions of the Restrictive Covenant in any capacity
identified in Paragraph 8, supra, and restricting third parties from aiding and abetting any violations of the Restrictive Covenant; and 

  

	 	c.	Compensatory damages, including actual loss from misappropriation and unjust enrichment, and any and all legal fees, including without limitation, all attorneys’ fees, court costs, and any other related fees and/or
costs incurred by the Company in enforcing this Agreement. 

 Notwithstanding the forgoing, the Company acknowledges and
agrees that the Employee will not be liable for the payment of any damages or fees owed to the Company through the operation of Paragraph 10c above, unless and until a court of competent jurisdiction has determined that the Company or any successor
is entitled to such recovery. 
 Nothing in this Agreement shall be construed as prohibiting the Company from pursuing any other legal or
equitable remedies available to it for actual or threatened breach of the provisions of Paragraphs 1 – 8 of this Agreement, and the existence of any claim or cause of action by Employee against the Company shall not constitute a defense to the
enforcement by the Company of any of the provisions of this Agreement. The Company and its Affiliated Entities have fully performed all obligations entitling it to the covenants of Paragraphs 1 – 8 of this Agreement and therefore such
prohibitions are not executory or otherwise subject to rejection under the bankruptcy code. 
 11. Duty to Disclose Agreement and to Report New
Employer. Employee acknowledges that the Company has a legitimate business purpose in the protection of its Confidential Information. Employee also recognizes and agrees that the Company has the right to such information as is reasonably
necessary to inform the Company whether the terms of this Agreement are being complied with. Accordingly, Employee agrees that Employee will promptly notify any new employer of his/her obligations contained here. Employee also will provide the
Company with the identity of his/her new employer(s) and a description of the services being provided by him/her in sufficient detail to allow the Company to reasonably determine whether such activities fall within the scope of activities prohibited
by the provisions of this Agreement 

  
 8 

 12. Representations as to Prior or Other Agreements. Employee represents and warrants that he/she
is able to perform the contemplated duties of employment without being in breach of confidentiality agreements or disclosing proprietary information of any third party, and that no proprietary information of any third party shall be disclosed to the
Company. Employee further represents and warrants that he/she is not prohibited from entering into this Agreement or performing services under it by any non-competition, non-solicitation, anti-piracy agreement, relationship agreement, or any other
restrictions. Employee agrees to indemnify and hold the Company harmless from all claims or causes of action by any person or entity against the Company arising out of any alleged breach by Employee of any such agreement or any other restrictions
inconsistent with the foregoing representations. 
 13. Company Use of Employee Name, Image and Voice. The Company may use and publish
Employee’s name and picture, including audio or video tape recordings, for purposes relating to its business without a specific release from Employee. 

14. Termination. Employee agrees to bring any claims that he/she may have against the Company within three hundred (300) days of the day
that Employee knew, or should have known, of the facts giving rise to the cause of action and waives any longer, but not shorter, statutory or other limitations periods. This includes, but is not limited to, the initial filing of a charge with the
Equal Employment Opportunity Commission and/or state equivalent civil rights agency. However, Employee understands that he/she will thereafter have the right to pursue any federal claim in the manner prescribed in any right to sue letter that is
issued by an agency. 
 15. Nondisparagement. Employee shall not make any disparaging or defamatory comments about the Company, whether true or
not, except to comply with any summons, court order or subpoena. 
 16. Waiver of Jury Trial. THE COMPANY AND EMPLOYEE EACH WAIVE ANY RIGHT TO A
TRIAL BY JURY IN ANY ACTION OR PROCEEDING TO ENFORCE OR DEFEND ANY RIGHTS UNDER THIS AGREEMENT OR UNDER ANY INSTRUMENT, DOCUMENT OR AGREEMENT DELIVERED IN CONNECTION HEREWITH OR HEREAFTER OR RELATED IN ANY FASHION TO EMPLOYEE’S EMPLOYMENT WITH
COMPANY. 
 17. Governing Law, Venue and Personal Jurisdiction. This Agreement shall be governed by, construed and enforced in accordance
with the laws of state of Florida without regard to any statutory or common-law provision pertaining to conflicts of laws. The parties agree that courts of competent jurisdiction in Lee County, Florida and the United States District Court for the
Southern District of Florida shall have concurrent jurisdiction for purposes of entering temporary, preliminary and permanent injunctive relief and with regard to any action arising out of any breach or alleged breach of this Agreement. Employee
waives personal service of any and all process upon Employee and consents that all such service of process may be made by certified or registered mail directed to Employee at the address stated in the signature section of this Agreement, with
service so made deemed to be completed upon actual receipt thereof. Employee waives any objection to jurisdiction and venue of any action instituted against Employee as provided herein and agrees not to assert any defense based on lack of
jurisdiction or venue. Employee further agrees that any action arising out of this Agreement or the relationship between the parties established herein shall be brought only in courts of competent jurisdiction in Lee County, Florida or the United
States District Court for the Southern District of Florida. 
 18. Successors and Assigns. This Agreement shall be binding upon and inure to
the benefit of the Parties hereto and may not be assigned by Employee. This Agreement shall inure to the benefit of Company’s successors. 
  

	19.	 Entire Agreement. This Agreement is the entire agreement of the Parties with regard to the

  
 9 

 
matters addressed herein, and supersedes all prior negotiations, preliminary agreements, and all prior and contemporaneous discussions and understandings of the signatories in connection with
the subject matter of this Agreement, except however, that this Agreement shall be read in pari materia with the Employment Agreement executed by Employee. This Agreement may be modified only by written instrument signed by the
Company and Employee. 
 20. Severability. In case any one or more provisions contained in this Agreement shall, for any reason, be held
invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provision hereof and this Agreement shall be construed as if such invalid, illegal were unenforceable provision had not been
contained herein. 
 21. Waiver. The waiver by the Company of a breach or threatened breach of this Agreement by Employee cannot be construed
as a waiver of any subsequent breach by Employee unless such waiver so provides by its terms. The refusal or failure of the Company to enforce any specific restrictive covenant in this Agreement against Employee, or any other person for any reason,
shall not constitute a defense to the enforcement by the Company of any other restrictive covenant provision set forth in this Agreement. 
 22.
Consideration. Employee expressly acknowledges and agrees that the execution by the Company of the Employment Agreement with the Employee constitutes full, adequate and sufficient consideration to Employee for the covenants of Employee
under this Agreement. 
 23. Notices . All notices required by this Agreement shall be in writing, shall be personally delivered or sent by
U.S. Registered or Certified Mail, return receipt requested, and shall be addressed to the signatories at the addresses shown on the signature page of this Agreement. 

24. Acknowledgements. Employee acknowledge(s) that he or she has reviewed this Agreement prior to signing it, that he or she knows and
understands the contents, purposes and effect of this Agreement, and that he or she has been given a signed copy of this Agreement for his or her records. Employee further acknowledges and agrees that he or she has entered into this Agreement
freely, without any duress or coercion. 
 25. Captions. Captions to paragraphs and sections of this Agreement have been included solely for
the sake of convenient reference and are entirely without substantive effect. 
 26. Counterparts. This Agreement may be executed in
counterparts, by facsimile or Adobe Acrobat pdf file each of which shall be deemed an original for all intents and purposes. 

[Signatures Appear on the Following Page] 

  
 10 

 IN WITNESS WHEREOF, THE UNDERSIGNED STATE THAT THEY HAVE CAREFULLY READ THIS AGREEMENT AND KNOW
AND UNDERSTAND THE CONTENTS THEREOF AND THAT THEY AGREE TO BE BOUND AND ABIDE BY THE REPRESENTATIONS, COVENANTS, PROMISES AND WARRANTIES CONTAINED HEREIN. 

							
				
	By:	 	/s/ Robert J. Shovlin	 	 	 	09/18/14
		 	 Employee Signature
	 		 	 Date

			
		
	Employee Name:	 	Robert J. Shovlin
		
	Employee Address:	 	15 Pine Tree Road
		
		 	Ramsey, NJ 07446
		
		 	 

 NeoGenomics Laboratories, Inc. 

12701 Commonwealth Drive, Suite #5 
 Fort Myers, FL 33913 

					
			
	By:	 	/s/ Douglas VanOort	 	09/16/14
		 		 	Date

			
		
	Name:	 	Douglas VanOort
		
	Title:	 	Chairman and CEO

  
 11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00236-of-00352.parquet"}]]